Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153282 · ClinicalTrials.gov registry record
Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 25
- Enrollment target
NCT01153282: Completed study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT01153282 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01153282 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Determine the characteristics of symptoms and functional impairment associated with chemotherapy induced peripheral neuropathy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-05 |
What the finished NCT01153282 record still lists
NCT01153282 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01153282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01153282 about?
NCT01153282 is a clinical study titled "Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer". Determine the characteristics of symptoms and functional impairment associated with chemotherapy induced peripheral neuropathy.
What is the current status of trial NCT01153282?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2010-06. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01153282?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia